Tracking how long arthritis patients stick with new treatment
NCT ID NCT06247722
Summary
This study is observing 600 people with moderate to severe rheumatoid arthritis who are already prescribed a medication called Tyenne. Researchers will follow these patients for 12 months to see how many continue taking the drug and if their arthritis symptoms improve. The goal is to understand how well this treatment works in everyday medical practice, not in a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Facharztpraxis für Innere Medizin
Naumburg, 06618, Germany
-
Facharztpraxis für Innere Medizin Ludwigsfelde
Ludwigsfelde, 14974, Germany
-
Klinische Forschung
Planegg, 82152, Germany
-
Rheumahaus Potsdam
Potsdam, 14467, Germany
-
Rheumapraxis Dr. Liebhaber Halle
Halle, 06128, Germany
-
Rheumatologische Facharztpraxis
Magdeburg, 39104, Germany
-
Rheumatologische Facharztpraxis Templin
Templin, 17268, Germany
-
Rheumatologische Schwerpunktpraxis Berlin
Berlin, 12161, Germany
Conditions
Explore the condition pages connected to this study.